ROBERT M. MILLER, PH.D., CCC-SLP
Speech Language Pathology at Pacific St, Seattle, WA
License number
Washington LL00003162
Category
Speech Language Pathology
Type
Speech-Language Pathologist
Address
Address
1959 NE Pacific St, Seattle, WA 98195
Phone
(206) 543-5440
(206) 616-1185 (Fax)
(206) 598-8920
(206) 598-7663 (Fax)
(206) 616-1185 (Fax)
(206) 598-8920
(206) 598-7663 (Fax)
Professional information
Independent Arts And Crafts Professional
Location:
Greater Seattle Area
Industry:
Arts and Crafts
Work:
woodworking By Design
Jun 1982 - Jan 2011
-
Owner
Education:
Northrop Institute of Technology 1962 - 1965
BSEE, Electronic Engineering
BSEE, Electronic Engineering
General Manager At Wired Media And Theater
Position:
General Manager at Wired Media and Theater
Location:
Greater Seattle Area
Industry:
Consumer Electronics
Work:
Wired Media and Theater
since Jan 2002
-
General Manager
Project Guy At Turner Construction
Position:
Project Guy at Turner Construction
Location:
Greater Seattle Area
Industry:
Construction
Work:
Turner Construction
-
Project Guy
V.p. Owner At Mht Insurance
Position:
V.P. OWNER at MHT INSURANCE
Location:
Greater Seattle Area
Industry:
Insurance
Work:
MHT INSURANCE
-
V.P. OWNER
Robert Miller
Location:
Greater Seattle Area
Industry:
Information Technology and Services
Method Of Enhancing Lymphocyte-Mediated Immune Responses
US Patent:
2004024, Dec 9, 2004
Filed:
May 27, 2004
Appl. No.:
10/399116
Inventors:
David Lynch - Seattle WA, US
Thibaut De Smedt - Seattle WA, US
Charles Maliszewski - Seattle WA, US
Eric Butz - Seattle WA, US
Robert Miller - Seattle WA, US
Thibaut De Smedt - Seattle WA, US
Charles Maliszewski - Seattle WA, US
Eric Butz - Seattle WA, US
Robert Miller - Seattle WA, US
International Classification:
A61K038/20
US Classification:
424/085200, 514/012000
Abstract:
An improved method for treatment of an individual suffering from or at risk for an infectious disease, comprising administering to said individual a combination of from two to five agents is disclosed. The agents may be agents that mobilize dendritic cells, agents that cause death or growth inhibition of infectious agents, chemoattractants, agents that stimulate maturation of dendritic cells, and agents that enhance an immune response of an effector T cell. Antigen-expressing, activated dendritic cells are disclosed. Such dendritic cells are used to present antigens (specifically, antigens derived from infectious agents) to T cells, and can be useful in vaccination protocols. Useful cytokines can be used in separate sequential or simultaneous combination with the activated, antigen-pulsed dendritic cells. Also disclosed are methods for stimulating an immune response using the antigen-expressing, activated dendritic cells.
Vice Pres. At Miller Hansen &Amp; Torphy
Position:
Vice.Pres. at MILLER HANSEN & TORPHY
Location:
Greater Seattle Area
Industry:
Insurance
Work:
MILLER HANSEN & TORPHY
since Jun 1983
-
Vice.Pres.
Interests:
Boating, Snow Skiing, Hockey, Washington Huskies Football
Table
US Patent:
D565331, Apr 1, 2008
Filed:
Nov 23, 2005
Appl. No.:
29/243358
Inventors:
Robert Miller - Seattle WA, US
Assignee:
Bohlin Cywinski Jackson - Seattle WA
International Classification:
0603
US Classification:
D 6485
Independent Maritime Professional
Location:
Greater Seattle Area
Industry:
Maritime
Robert Miller
Location:
Greater Seattle Area
Industry:
Telecommunications